Friday, September 12, 2014

Question of the Day September 12, 2014 Should the FDA pursue litigation against NuVision/Downing Labs? Should it have to do so? What is the Texas State Pharmacy Board Doing in this matter? Why is the Texas Board of Pharmacy apparently more concerned with nonresident compounding pharmacies than it is with the actions of its own resident compounding pharmacies? Why don't other agencies in Texas such as the state attorney general's office pursue more actions against compounding pharmacies?


1 comment:

Anonymous said...

One might also ask where the state public health officials are...

1. Repackaged chemical ingredients--> arising from unsecured supply chain?

2. Formulas--> sold without warranty?

3. Assembly into final products--> absent FDA finding of safety, efficacy, and manufacturing quality; absent product liability insurance?

Health officials should ask, what medical needs would justify this level of risk and uncertainty?